EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Trending
-
Connecting the dots: M&A deals in the technology services in 2024
11 Mar 2025 Mergers and acquisitions -
How global companies can demystify complex global bank fee structure
10 Mar 2025 -
Paving the road to Viksit Bharat with economic opportunities for women
07 Mar 2025 Diversity, equity and inclusiveness
Select your location
Local sites
Life Sciences
Our Global Life Sciences sector can help you navigate forward and achieve sustainable success in the new health-outcomes-driven ecosystem.
Aging populations and chronic disease are putting pressure on health resources around the world just as scientific progress, augmented intelligence and digital data are transforming the traditional health care models. This is causing a power shift with new entrants (often not driven by profit) disrupting the incumbents.
Staying competitive and providing the personalized experience that patients demand require life sciences organizations to find new ways of working. Partnering with others to share data, medicine and resources while anticipating trends and regulatory changes will help ensure sustainability in the increasingly evidence-based, outcomes-focused sector.
We help companies across the biotechnology, pharmaceutical and medical technology fields harness this disruption by forming the right alliances, better allocating resources and building trust with customers.
Our latest thinking
AIdea 2025 report - Industries in transformation: Life Sciences
Discover how GenAI is reshaping the life sciences sector in India expecting productivity gains of 32%-34% by 2030. Learn about its role in drug discovery, manufacturing, quality management & the challenges.
14 Jan 2025
Suresh Subramanian
What will it take for India to become a global pharma powerhouse by 2047?
Unveiling India's roadmap to a $450 billion pharma industry by 2047 with digital transformation, AI-driven innovation, and strategic industry collaboration.
11 Dec 2024
Suresh Subramanian
India’s MedTech transformation: paving the path to global leadership
India's MedTech industry is undergoing a revolution. Explore the latest trends, government support, and the potential for global dominance. Learn more.
26 Nov 2024
Suresh Subramanian
Confronting India’s cancer crisis: The urgent need for affordable care
India battles rising cancer rates. Learn about challenges, prevention, early detection, and affordable treatment options. Know more.
05 Nov 2024
Srimayee Chakraborty
Transforming healthcare in India with Generative AI
Leverage GenAI in Indian healthcare: a collaborative strategy for high-quality, accessible care, balancing potential with mindful tech integration. Learn more.
30 Aug 2024
Kaivaan Movdawalla
Driving Competitive Differentiation: M&A Outlook for 2023 in Tech Services
Explore Indias healthcare evolution and future goals in our in-depth analysis. Uncover the strides and vision for a healthier India. Learn more.
25 Jun 2024
EY India
How sustainable practices ensure a green healthcare ecosystem
Discover how sustainability and climate change, two major megatrends, are profoundly impacting the entire healthcare ecosystem and its stakeholders. Learn more about green hospitals.
08 Mar 2024
Nitesh Mehrotra
How EY can help
-
The EY R&D Workbench for Pharma is a unique, customized End-to-End ERP solution. It integrates modules covering the entire pharmaceutical R&D and manufacturing lifecycle, including portfolio management, new product development, clinical development, launch, and regulatory management across multiple dosage forms, APIs, and biosimilars. Organizations can benefit from improved market speed, transparency, and accountability across departments.
Read more -
EY-Parthenon Health and Wellness Strategy Consulting teams help develop and deliver growth, transaction, digital and value creation strategies. We help health and life sciences organizations build greater financial and operational resilience and technical agility, supporting their future growth within an ever-changing landscape.
Read more
Meet our Life Sciences consulting team
Direct to your inbox
Stay up to date with our Editor's picks newsletter.